cbdMD YCBD
NYSE YCBD
$0.51 +0.00 (+0.77%)
As of: Aug 21, 2026 · 3:59 PM EDT

cbdMD (YCBD) Other Non-Current Liabilities (2018 - 2023)

cbdMD (YCBD) posted Other Non-Current Liabilities of $20611.0 for Q4 2023, down 77.19% sequentially from $90363.0 in Q3 2023, and down 87.2% YoY from $161000.0 in Q4 2022.

cbdMD (YCBD) Other Non-Current Liabilities (2018 - 2023) Analysis & Trends

cbdMD has reported Other Non-Current Liabilities for 6 years, with the latest figure at $20611.0 in Q4 2023.

  • Quarterly Other Non-Current Liabilities fell 87.2% year-over-year to $20611.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $20611.0 (down 87.2% YoY) and the FY2023 annual result came in at $90363.0, down 67.26% from the prior year.
  • Other Non-Current Liabilities slipped to $20611.0 in Q4 2023 per YCBD's latest filing, from $90363.0 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $102.3 million in Q1 2019 and troughed at $13000.0 in Q1 2022.
  • A 5-year average of $15.8 million and a median of $276000.0 in 2022 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities plunged 99.94% in 2022, then jumped 1184.62% in 2023.
  • Over 5 years, Other Non-Current Liabilities stood at $33.7 million in 2019, then sank by 51.93% to $16.2 million in 2020, then tumbled by 99.01% to $161000.0 in 2021, then changed by 0.0% to $161000.0 in 2022, then slumped by 87.2% to $20611.0 in 2023.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $20611.0, $90363.0, and $122230.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 cbdMD 5.41 Mn 3.29 Mn 3.04 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 20,611.00
Sep 30, 2023 90,363.00
Jun 30, 2023 122,230.00
Mar 31, 2023 167,000.00
Dec 31, 2022 161,000.00
Sep 30, 2022 276,000.00
Mar 31, 2022 13,000.00
Dec 31, 2021 161,000.00
Sep 30, 2021 9.86 Mn
Jun 30, 2021 920,000.00
Mar 31, 2021 22.30 Mn
Sep 30, 2020 16.20 Mn
Dec 31, 2019 33.70 Mn
Sep 30, 2019 50.60 Mn
Mar 31, 2019 102.27 Mn
Dec 31, 2018 71.35 Mn
Jun 30, 2018 8,004.00